Olivier Harari

5.4k total citations
37 papers, 1.9k citations indexed

About

Olivier Harari is a scholar working on Immunology, Rheumatology and Immunology and Allergy. According to data from OpenAlex, Olivier Harari has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 12 papers in Rheumatology and 9 papers in Immunology and Allergy. Recurrent topics in Olivier Harari's work include Cell Adhesion Molecules Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Complement system in diseases (6 papers). Olivier Harari is often cited by papers focused on Cell Adhesion Molecules Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Complement system in diseases (6 papers). Olivier Harari collaborates with scholars based in United Kingdom, United States and Germany. Olivier Harari's co-authors include James K. Liao, Dorian O. Haskard, Julie McHale, Diane Marshall, Benjamin Porter-Brown, Liz Thompson, Maxime Dougados, Joachim Sieper, Justin C. Mason and J C Kaski and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Olivier Harari

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olivier Harari United Kingdom	20	839	571	428	243	214	37	1.9k
Yoriaki Kaneko Japan	26	1.3k 1.6×	417 0.7×	529 1.2×	362 1.5×	48 0.2×	91	2.6k
Helen M. McGettrick United Kingdom	25	854 1.0×	204 0.4×	727 1.7×	119 0.5×	71 0.3×	79	2.1k
Tania Colasanti Italy	25	525 0.6×	651 1.1×	595 1.4×	169 0.7×	61 0.3×	66	1.8k
Stefano Alivernini Italy	26	851 1.0×	963 1.7×	876 2.0×	333 1.4×	39 0.2×	85	2.6k
Alessandra Nerviani United Kingdom	24	925 1.1×	674 1.2×	495 1.2×	220 0.9×	31 0.1×	49	1.8k
Niansheng Yang China	33	1.9k 2.2×	800 1.4×	1.2k 2.7×	209 0.9×	52 0.2×	66	3.3k
Sten Stemme Sweden	27	2.3k 2.7×	359 0.6×	773 1.8×	95 0.4×	126 0.6×	47	3.5k
Kusumam Joseph United States	31	755 0.9×	563 1.0×	503 1.2×	610 2.5×	52 0.2×	70	2.5k
John Doukas United States	20	489 0.6×	103 0.2×	836 2.0×	246 1.0×	67 0.3×	35	1.9k
Muriel Gaudry France	25	741 0.9×	104 0.2×	909 2.1×	270 1.1×	53 0.2×	36	1.9k

Countries citing papers authored by Olivier Harari

Since Specialization

Citations

This map shows the geographic impact of Olivier Harari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Harari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Harari more than expected).

Fields of papers citing papers by Olivier Harari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Harari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Harari. The network helps show where Olivier Harari may publish in the future.

Co-authorship network of co-authors of Olivier Harari

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Harari. A scholar is included among the top collaborators of Olivier Harari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Harari. Olivier Harari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Litcher‐Kelly, Leighann, Ahmet Özen, Hagit Baris Feldman, et al.. (2025). The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition. Orphanet Journal of Rare Diseases. 20(1). 68–68. 1 indexed citations

Litcher‐Kelly, Leighann, Ahmet Özen, Hagit Baris Feldman, et al.. (2024). Pozelimab for CHAPLE disease: results from in-trial interviews and clinical outcome assessments. Orphanet Journal of Rare Diseases. 19(1). 290–290. 3 indexed citations

Wipperman, Matthew F., Andreja Avberšek, Robin R. Deterding, et al.. (2022). A pilot study of the Earable device to measure facial muscle and eye movement tasks among healthy volunteers. arXiv (Cornell University). 1 indexed citations

Wang, Claire Q., Sokol Haxhinasto, Sandra Garcet, et al.. (2022). Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis. Journal of Investigative Dermatology. 143(1). 87–97.e14. 12 indexed citations

Jang, Jun‐Ho, Jonathan Weyne, Umesh Chaudhari, et al.. (2021). Pozelimab, a Human Monoclonal Antibody Against Complement Factor C5, Provided Inhibition of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 138(Supplement 1). 1128–1128. 6 indexed citations

Isaacs, John D., Olivier Harari, Uwe Kobold, Janet Lee, & Corrado Bernasconi. (2013). Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis. Arthritis Research & Therapy. 15(6). R204–R204. 75 indexed citations

Wang, Jianmei, Adam Platt, Ruchi Upmanyu, et al.. (2013). IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis. BMJ Open. 3(8). e003199–e003199. 50 indexed citations

Sieper, Joachim, Benjamin Porter-Brown, Liz Thompson, Olivier Harari, & Maxime Dougados. (2013). Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials. Annals of the Rheumatic Diseases. 73(1). 95–100. 158 indexed citations

Klearman, Micki, et al.. (2013). FRI0132 Insulin resistance is improved by tocilizumab therapy in rheumatoid arthritis: results from the toward study. Annals of the Rheumatic Diseases. 72. A414–A415. 7 indexed citations

10.

Sieper, J., Benjamin Porter-Brown, Liz Thompson, Olivier Harari, & Maxime Dougados. (2012). OP0166 Tocilizumab (TCZ) is not effective for the treatment of ankylosing spondylitis (AS): Results of a phase 2, international, multicentre, randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 71. 110–111. 18 indexed citations

11.

Bansal, Aruna T., Søren Germer, Ryma Benayed, et al.. (2012). Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis. The Pharmacogenomics Journal. 13(3). 235–241. 39 indexed citations

12.

Harari, Olivier & James K. Liao. (2010). NF‐κB and innate immunity in ischemic stroke. Annals of the New York Academy of Sciences. 1207(1). 32–40. 271 indexed citations

13.

Recio‐Mayoral, Alejandro, Justin C. Mason, J C Kaski, et al.. (2009). Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. European Heart Journal. 30(15). 1837–1843. 160 indexed citations

14.

Harari, Olivier, Elaine A. Lidington, Joseph J. Boyle, et al.. (2007). A Protein Kinase Cε-Anti-apoptotic Kinase Signaling Complex Protects Human Vascular Endothelial Cells against Apoptosis through Induction of Bcl-2. Journal of Biological Chemistry. 282(44). 32288–32297. 41 indexed citations

15.

Harari, Olivier & James K. Liao. (2004). Inhibition of MHC II Gene Transcription by Nitric Oxide and Antioxidants. Current Pharmaceutical Design. 10(8). 893–898. 116 indexed citations

16.

Stocker, Claire J., Katharine L. Sugars, Olivier Harari, et al.. (2000). TNF-α, IL-4, and IFN-γ Regulate Differential Expression of P- and E-Selectin Expression by Porcine Aortic Endothelial Cells. The Journal of Immunology. 164(6). 3309–3315. 58 indexed citations

17.

McHale, Julie, Olivier Harari, Diane Marshall, & Dorian O. Haskard. (1999). Vascular Endothelial Cell Expression of ICAM-1 and VCAM-1 at the Onset of Eliciting Contact Hypersensitivity in Mice: Evidence for a Dominant Role of TNF-α. The Journal of Immunology. 162(3). 1648–1655. 87 indexed citations

18.

McHale, Julie, Olivier Harari, Diane Marshall, & Dorian O. Haskard. (1999). TNF-α and IL-1 Sequentially Induce Endothelial ICAM-1 and VCAM-1 Expression in MRL/ lpr Lupus-Prone Mice. The Journal of Immunology. 163(7). 3993–4000. 95 indexed citations

19.

Harari, Olivier, Julie McHale, Diane Marshall, et al.. (1999). Endothelial Cell E- and P-Selectin Up-Regulation in Murine Contact Sensitivity Is Prolonged by Distinct Mechanisms Occurring in Sequence. The Journal of Immunology. 163(12). 6860–6866. 45 indexed citations

20.

Harari, Olivier, Thomas J. Wickham, Imre Kovesdi, et al.. (1999). Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin. Gene Therapy. 6(5). 801–807. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact